Growth Metrics

Vivos Therapeutics (VVOS) Other Non-Current Liabilities (2022 - 2025)

Vivos Therapeutics (VVOS) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $1.4 million as the latest value for Q3 2025.